News

Explore Growth Opportunities with Marvell Technology Stock

Explore Growth Opportunities with Marvell Technology Stock

Broadcom and Marvell Technology: Competing in the AI Chip Market

Over the past year, shares of Broadcom (NASDAQ: AVGO) have soared by 82%, largely due to the company's strong presence in the market for custom artificial intelligence (AI) chips. This impressive performance has significantly strengthened its semiconductor business. Expert analysts now recognize Broadcom as one of the top firms in the AI chip sector, second only to Nvidia.

Broadcom has established a commanding position in the application-specific integrated circuits (ASICs) market, where it holds an estimated market share of 55% to 60%. This dominance has begun to translate into substantial returns for investors, although it has also led to Broadcom trading at a high valuation of 17 times sales and 70 times trailing earnings. Such elevated prices may deter some investors from making additional investments in Broadcom, prompting them to explore other options.

One alternative worth considering is Marvell Technology (NASDAQ: MRVL). Let’s explore why investing in Marvell could be a wise decision.

Marvell Technology: Riding the AI Wave

Marvell Technology recently announced its fiscal Q2 results, revealing a 5% decline in revenue to $1.27 billion compared to the same period last year. Additionally, its non-GAAP earnings fell by 9% to $0.30 per share. Surprisingly, these results led to a more than 9% surge in Marvell's stock price following the announcement, despite the drop in both revenue and earnings.

The reason behind this positive investor reaction becomes evident when examining Marvell's data center business. In the last quarter, the company generated $881 million in sales from its data center chip segment, reflecting a remarkable 92% year-over-year increase. This segment now accounts for 69% of Marvell's total revenue, and the outlook is even brighter as the company scales up production of its AI chips.

During the latest earnings call, Marvell’s CEO Matthew Murphy shared that the company's efforts in developing custom silicon for AI are progressing well. They have recently commenced volume production of their first two custom AI chips and have secured key projects with clients that align with significant milestones.

Murphy also forecasted strong growth for their data center revenue, anticipating sequential growth in the high teens percentage-wise for fiscal Q3, indicating a recovery from the previous quarter's 8% decline. Excitingly, Marvell aims to surpass its forecast of $1.5 billion in AI-related revenue for fiscal 2025.

Sustainable Growth and Market Positioning

Marvell is well-positioned to sustain its impressive growth in AI-related revenue, thanks to its current backlog of orders and sufficient supply to meet ongoing demand. The custom AI chip market is thriving, with analysts estimating a total revenue potential of $150 billion over the next four to five years. While Broadcom is in a favorable position to benefit from this growth, Marvell is also a strong competitor, holding a 15% share of the ASIC market.

This increasing market share is positively impacting Marvell's data center business, as reflected in their latest guidance, which suggests revenue of $1.45 billion and adjusted earnings of $0.40 per share for the current quarter, indicating a return to growth compared to last year's figures.

Marvell Technology: A Sound Investment Option

Although Marvell’s earnings for fiscal 2025 may see a slight decline from the previous year’s $1.51 per share, the company expects a significant growth surge starting in fiscal 2026. This potential acceleration may present a valuable opportunity for investors.

With a price-to-sales ratio of 12.5 and a forward earnings multiple of 30, Marvell appears relatively more affordable compared to its competitors. If Marvell can achieve $3.41 per share in earnings over the next couple of years, and the stock trades at 30 times earnings, the price could rise to $102, representing a 34% increase from current levels, with further upside possible given the demand for AI chips.

Is Now the Right Time to Invest in Marvell Technology?

As you contemplate investing in Marvell Technology, it's crucial to stay updated on the company's performance and market positioning. Analysts are optimistic about Marvell's future, given its strong standing in the AI sector.

Frequently Asked Questions

1. Why is Marvell Technology a good investment option?

Marvell Technology is well-positioned in the rapidly growing AI chip market, demonstrating significant growth in its data center business and promising future revenue projections.

2. How does Marvell's market share compare to Broadcom?

Marvell holds approximately 15% of the ASIC market, while Broadcom dominates with a share of 55% to 60%.

3. What does the future hold for Marvell's earnings?

While earnings may decrease slightly for fiscal 2025, strong growth is anticipated starting in fiscal 2026, making it an appealing long-term investment.

4. What is the expected revenue growth for Marvell's data center segment?

Marvell anticipates data center revenue growth to accelerate into the high teens percentage-wise in the current quarter.

5. What is the significance of the custom AI chip market?

The custom AI chip market presents a substantial growth opportunity with an estimated revenue potential of $150 billion over the next four to five years.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Happiest Minds Extends Absa Banking Platform Reach

Updated Category News Views 34

Mauritius just handed Happiest Minds a useful, if modest, banking-tech scorecard. On November 19, 2026, the company said its cloud-native Arttha platform had been deployed to support selected capabilities within Spark by Absa, a digital banking and lifestyle app from Absa Bank (Mauritius). This is not the sort of announcement that lets anybody pencil in a giant revenue...

Continue Reading
California Budget Warning Puts Reserves Back in Focus

Updated Category News Views 118

California’s rainy-day umbrella is getting another hard look, and it should. State Controller Malia M. Cohen is pointing to the Legislative Analyst’s Office fiscal outlook as a reminder that budget discipline and stronger reserves are not ornamental good-government phrases. They are the difference between absorbing a revenue wobble and reaching for ugly fixes after...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 0

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 34

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
Youdao Sets December AGM With No Vote on the Table

Updated Category News Views 74

A shareholder meeting without a vote is more temperature check than showdown, and that is exactly what Youdao has scheduled for December 17, 2026. The company will gather shareholders from 3:00 p.m. to 5:00 p.m. Beijing time at its Beijing office, but it has made one point painfully clear: no proposal will be submitted for shareholder approval. For holders of NYSE: DAO,...

Continue Reading
JOYY Q3 Growth Shows More Than Livestreaming Muscle

Updated Category News Views 39

Revenue finally has more than one pair of legs at JOYY, and that matters a whole lot more than a flashy quarterly headline. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% from the prior quarter. Those are not microscopic moves, and the composition is the part that deserves the hard stare. JOYY is still rooted in...

Continue Reading
A Hybrid Book Bets on Muscles, Myth, and Machines

Updated Category News Views 66

Few publishing pitches ask readers to carry a barbell into Tartarus, but A R Quigley is plainly not chasing the middle of the bookstore. Doctrina Machina Learning Machine, released by Palmetto Publishing in November 2026, welds together a strength-training guide and an underground military science-fiction war story. That is an odd little contraption, no use pretending...

Continue Reading
Innoviz's 1-for-20 Split Is a Listing Lifeline Test

Updated Category News Views 93

A twenty-share pile of INVZ is about to become one share, and nobody should confuse that paperwork with a turnaround. Innoviz plans to enact a 1-for-20 reverse split at 11:59 p.m. Eastern on Friday, December 4, with split-adjusted trading expected when Nasdaq opens on December 7. This is a blunt instrument aimed at one immediate problem: getting the quoted share price...

Continue Reading
SAGA's Radar Assays Tighten the Trapper North Case

Updated Category News Views 188

Rock that keeps showing up where the model says it should is the sort of boring news a junior miner desperately needs. SAGA Metals has put out fresh assay results from Radar’s Trapper North area, and the useful part is not merely a loud grade in one hole. It is the apparent persistence of thick titanium-vanadium-iron oxide mineralization across tighter-spaced drilling....

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 169

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading

Top 5 Most Recently Viewed Articles

Galderma Showcases Innovations in Dermatology at EADV 2024

Updated Category News Views 262

Galderma's Role at EADV 2024 At the upcoming European Academy of Dermatology and Venereology (EADV) congress, Galderma is set to highlight its important advancements in dermatology. This congress serves as a vital platform where dermatology professionals come together to exchange knowledge, explore new insights, and delve into the latest developments within the field....

Continue Reading
Exploring Growth Factors in the Scoliosis Management Sector

Updated Category News Views 131

Growth Potential in the Scoliosis Management Market Recent analyses reveal an exciting trajectory for the global scoliosis management market, projected to reach a remarkable $4.39 billion by 2034. This growth is fueled by an expected compound annual growth rate (CAGR) of 3.7% throughout the period. A significant push behind this bright future comes from the increasing...

Continue Reading
Celebrating 5 Years of Luxury Home Building with JASPER

Updated Category News Views 375

JASPER Marks Five Years of Distinctive Home Building JASPER, Nashville's foremost luxury builder, takes pride in celebrating five remarkable years of creating custom homes and inspiring renovations with a focus on precision, honesty, and a customer-centered approach. Establishing a Reputable Foundation Since its inception, JASPER has become synonymous with quality in...

Continue Reading
La Rosa Holdings Strengthens Agent Platform for Growth

Updated Category News Views 92

La Rosa Holdings Enhances Agent Platform La Rosa Holdings Corp. (NASDAQ:LRHC) has recently unveiled an upgraded version of its proprietary platform, My Agent Account, which includes a new property management module aimed at increasing operational efficiency for its agents. The My Agent Account platform has been gaining traction, evidenced by a remarkable 19%...

Continue Reading
Alkaline Water Company Partners for Expansion in New Markets

Updated Category News Views 153

Alkaline Water Company Enhances Global Presence The Alkaline Water Company, Inc. (OTC: WTER), known for its premium hydration solutions, has recently made significant strides in expanding its international footprint. In a notable move, the company has entered into a strategic international sales and distribution agreement with Global Brand and Export Development, LLC....

Continue Reading